Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-Diabetic (Sulfonylurea and Metformin) or Insulin from the Perspective of Bone